Master New Jersey Supreme Court established standards for withholding or withdrawing life-sustaining treatment, including artificial nutrition and hydration, from incompetent patients. with this comprehensive case brief.
In re Conroy is a foundational end-of-life decision from the New Jersey Supreme Court that clarified when life-sustaining medical treatment, including artificial nutrition and hydration, may be withheld or withdrawn from an incompetent adult who never executed a formal directive. Building on In re Quinlan, the Court articulated a nuanced framework that respects patient autonomy while recognizing compelling state interests, and it provided practical standards to guide families, physicians, and courts.
The case is significant because it rejected categorical distinctions that would have insulated artificial nutrition and hydration from refusal, identified three decision-making standards (subjective, limited-objective, pure-objective) keyed to the quality of evidence and the burdens of treatment, and outlined procedural safeguards for surrogate decision-making. Conroy became a touchstone for right-to-die jurisprudence nationwide and influenced later state and federal cases on surrogate consent and the withdrawal of life-sustaining care.
In re Conroy, 98 N.J. 321, 486 A.2d 1209 (N.J. 1985)
An elderly woman, approximately 84 years old, resided in a nursing home and suffered from severe, irreversible cognitive impairment consistent with advanced organic brain syndrome. She was bedridden, frail, and afflicted by multiple serious medical conditions, including recurrent infections and decubitus ulcers. Because she could no longer safely swallow, her treating physician inserted a nasogastric (NG) tube to provide artificial nutrition and hydration. She had executed no advance directive and left no formal instructions about end-of-life care. A close relative, acting as guardian, petitioned for authorization to discontinue the NG tube, asserting that continued tube feeding was burdensome and not in her best interests. The trial court authorized cessation of artificial feeding, but the Appellate Division reversed, suggesting that withdrawal of nutrition and hydration might constitute abuse under state elder-protection statutes and intimating that feeding was different from other medical treatment. The New Jersey Supreme Court granted review to resolve whether, and under what standards, a surrogate may refuse life-sustaining treatment for an incompetent patient, particularly artificial nutrition and hydration.
May a surrogate decision-maker withhold or withdraw life-sustaining medical treatment—specifically artificial nutrition and hydration—from an incompetent adult who left no clear directive, and if so, under what standards and procedural safeguards?
An incompetent patient possesses the same right as a competent patient to refuse medical treatment, grounded in common-law principles of bodily integrity and informed consent. That right may be exercised on the patient's behalf by a surrogate under one of three standards, applied from the patient's perspective: 1) Subjective test: If there is clear and convincing evidence that the particular patient would have refused the treatment under the circumstances, that preference controls. 2) Limited-objective test: If some trustworthy evidence suggests the patient would have declined the treatment, and the burdens of the patient's continued life with the treatment clearly outweigh the benefits to that patient, treatment may be withheld. 3) Pure-objective test: If no reliable evidence of the patient's wishes exists, treatment may be withheld only if the burdens of the patient's continued life with the treatment clearly and markedly outweigh the benefits to that patient, such that continued treatment would be inhumane. Artificial nutrition and hydration are medical treatments subject to the same analysis as other life-sustaining measures. State interests in preserving life, preventing suicide, protecting third parties, and maintaining the ethical integrity of the medical profession do not invariably override the patient's right when the applicable standard is met. Court involvement is not invariably required; however, decisions should follow procedural safeguards, including medical confirmation of diagnosis and prognosis, careful documentation, and, where appropriate, consultation with an independent physician, institutional review mechanisms (e.g., ethics committee), and notice to protective agencies as required by statute. Judicial review is warranted when there is disagreement, uncertainty about the applicable standard, or concerns about conflicts of interest or abuse.
Yes. Artificial nutrition and hydration constitute medical treatment that may be withheld or withdrawn from an incompetent patient under carefully defined standards. The Court rejected a categorical bar on discontinuing tube feeding and held that surrogate decision-makers may refuse life-sustaining treatment on the patient's behalf when the subjective, limited-objective, or pure-objective test is satisfied, with appropriate safeguards. The Appellate Division's contrary approach was set aside, and the matter was remanded for proceedings consistent with these principles.
The Court began from settled common-law principles that a competent person has a right to refuse unwanted medical treatment. That right derives from bodily integrity and informed consent; treatment without consent is a battery. Incompetence does not erase the underlying right, but it complicates how the right is exercised. Building on Quinlan and decisions from other jurisdictions, the Court held that a surrogate may exercise the patient's right, but any analysis must be anchored in the particular patient—her values, preferences, and welfare—rather than in generalized notions of quality of life. Rejecting a categorical distinction between artificial feeding and other treatments, the Court reasoned that nasogastric tube feeding is a medical intervention initiated and sustained by healthcare providers, and thus falls within the domain of consent and refusal. The state's interests—preservation of life, prevention of suicide, protection of third parties, and preservation of medical ethics—do not invariably trump patient autonomy. Withdrawal of treatment at the end of life is not suicide; it is a decision to decline medical intervention, and physicians remain within the ethical tradition when they forgo nonbeneficial or excessively burdensome treatment. Because evidence of an incompetent patient's wishes varies in clarity and reliability, the Court calibrated three decision standards. The subjective test honors autonomy when the patient's prior statements or conduct provide clear and convincing evidence of her choice in these circumstances. If such clarity is lacking but there is some trustworthy indication of the patient's preferences, the limited-objective test allows discontinuation only when the burdens of continued life with treatment clearly outweigh benefits to the patient. Where no reliable evidence of wishes exists, the pure-objective test demands an even more stringent showing: the burdens must so clearly and substantially exceed any benefits that continued treatment would be inhumane. In all events, the calculus must be from the patient's viewpoint, considering the pain, invasiveness, indignities, and medical complications of treatment against the benefits the patient actually derives. To promote accuracy and guard against abuse, the Court outlined procedural safeguards. Surrogates and clinicians should confirm diagnosis and prognosis, obtain an independent medical opinion where appropriate, document the basis for the decision, and, if available, consult an ethics committee. Judicial involvement is unnecessary when there is consensus that one of the tests is met and no red flags exist; courts should be engaged when there is disagreement, uncertainty, or potential conflicts of interest. The Court also addressed elder-protection statutes, clarifying that lawful, rights-respecting withdrawal of treatment is not abuse and may proceed with appropriate notice to protective agencies where required. Applying these principles, the Court rejected the Appellate Division's categorical bar and remanded for fact-finding under the articulated standards.
Conroy is a cornerstone of right-to-die and surrogate decision-making law. It affirms that artificial nutrition and hydration are medical treatments that may be refused and provides a structured, evidence-sensitive framework—the subjective, limited-objective, and pure-objective tests—that has been widely adopted and cited. The case also operationalizes end-of-life decision-making by outlining safeguards that allow many decisions to be made at the bedside, reserving courts for contested or uncertain cases. For law students, Conroy illuminates how courts balance autonomy against state interests and translates constitutional and common-law principles into practical clinical guidance.
No. Conroy rejects categorical rules. Artificial nutrition and hydration may be withdrawn only if one of the three standards is met from the patient's perspective: (1) clear and convincing evidence of the patient's wish to refuse (subjective); (2) some trustworthy evidence plus a clear showing that burdens outweigh benefits (limited-objective); or (3) no evidence of wishes but an extraordinary imbalance where continued treatment would be inhumane (pure-objective), all with appropriate safeguards.
Both require that the burdens of the patient's continued life with treatment clearly outweigh the benefits to that patient. The limited-objective test also requires some trustworthy evidence of the patient's likely wishes. The pure-objective test applies when no such evidence exists and therefore demands an even more compelling showing that treatment imposes severe, ongoing burdens such that continuation would be inhumane.
No. The Court expressly held that artificial nutrition and hydration are medical treatments initiated and maintained by clinicians, and thus fall within the same right to refuse treatment as ventilators, dialysis, or other life-sustaining interventions.
Not necessarily. If the applicable standard is satisfied, the surrogate and clinicians agree, and safeguards are followed (e.g., independent medical confirmation, documentation, ethics consultation where available), the decision may be made without prior judicial approval. Courts should be involved when there is disagreement, uncertainty about whether a standard is met, or concerns about conflicts of interest or possible abuse.
A valid advance directive typically supplies the clear and convincing evidence required by the subjective test, making the surrogate's and clinician's task more straightforward. Conroy fills the gap when no directive exists by defining how to proceed using the limited-objective and pure-objective tests.
Quinlan recognized a constitutional privacy right to discontinue ventilatory support for a permanently unconscious patient. Conroy extended the analysis to artificial nutrition and hydration and developed the three tests for incompetent patients who are not necessarily terminal or in a persistent vegetative state. Later, in Cruzan, the U.S. Supreme Court acknowledged states' authority to require clear and convincing evidence of a patient's wishes—an approach consistent with Conroy's subjective test.
In re Conroy brought critical clarity to end-of-life decision-making for incompetent patients. By treating artificial nutrition and hydration as medical treatment and calibrating decision standards to the quality of evidence and the burdens of care, the Court respected patient autonomy without abandoning compelling state interests. Its procedural guidance enabled many ethically sound decisions to be made outside courtrooms while preserving judicial oversight for contested or uncertain situations.
For law students, Conroy exemplifies how courts translate abstract principles—bodily integrity, informed consent, and the balance of state interests—into actionable rules for clinicians and families. It remains a leading case in health law and bioethics, shaping policy, professional norms, and the everyday practice of surrogate decision-making at the end of life.
Need to cite this case?
Generate a perfectly formatted Bluebook citation in seconds.
Use our Bluebook Citation Generator →